| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |